» Articles » PMID: 16216938

Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease

Overview
Journal Arch Neurol
Specialty Neurology
Date 2005 Oct 12
PMID 16216938
Citations 522
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vascular risk factors play a role in the development of dementia, including Alzheimer disease (AD). However, little is known about the effect of body mass index and clustering of vascular risk factors on the development of dementia.

Objective: To investigate the relation between midlife body mass index and clustering of vascular risk factors and subsequent dementia and AD.

Design And Setting: Participants of the Cardiovascular Risk Factors, Aging, and Dementia (CAIDE) study were derived from random, population-based samples previously studied in a survey carried out in 1972, 1977, 1982, or 1987. After an average follow-up of 21 years, 1449 individuals (73%) aged 65 to 79 years participated in the reexamination in 1998.

Main Outcome Measures: Dementia and AD.

Results: Obesity at midlife (body mass index>30 kg/m2) was associated with the risk of dementia and AD even after adjusting for sociodemographic variables (odds ratio [OR], 2.4 [95% confidence interval (CI), 1.2-5.1]). The association was somewhat modified by further adjusting for midlife blood pressure, total cholesterol level, and smoking (OR, 2.1 [95% CI, 1.0-4.6]) and also for apolipoprotein E genotype and history of vascular disorders (OR, 1.9 [95% CI, 0.8-4.6]). Midlife obesity, high total cholesterol level, and high systolic blood pressure were all significant risk factors for dementia with ORs of around 2 for each factor, and they increased the risk additively (OR, 6.2 for the combination).

Conclusions: Obesity at midlife is associated with an increased risk of dementia and AD later in life. Clustering of vascular risk factors increases the risk in an additive manner. The role of weight reduction for the prevention of dementia needs to be further investigated.

Citing Articles

Is late-life vulnerability to cardiovascular disease risk associated with longitudinal tau accumulation in older adults with mild cognitive impairment?.

Dratva M, Diaz J, Thomas M, Shen Q, Tsiknia A, Rostowsky K JAR Life. 2025; 14:100001.

PMID: 40046641 PMC: 11879684. DOI: 10.1016/j.jarlif.2025.100001.


Advancing Alzheimer's Disease Modelling by Developing a Refined Biomimetic Brain Microenvironment for Facilitating High-Throughput Screening of Pharmacological Treatment Strategies.

Mohd Murshid N, Mohd Sahardi N, Makpol S Int J Mol Sci. 2025; 26(1.

PMID: 39796097 PMC: 11719782. DOI: 10.3390/ijms26010241.


Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges.

Safiri S, Ghaffari Jolfayi A, Fazlollahi A, Morsali S, Sarkesh A, Daei Sorkhabi A Front Med (Lausanne). 2024; 11:1474043.

PMID: 39736972 PMC: 11682909. DOI: 10.3389/fmed.2024.1474043.


Dynamic relations between longitudinal morphological, behavioral, and emotional indicators and cognitive impairment: evidence from the Chinese Longitudinal Healthy Longevity Survey.

Sun J, Deng L, Li Q, Zhou J, Zhang Y BMC Public Health. 2024; 24(1):3516.

PMID: 39696204 PMC: 11657234. DOI: 10.1186/s12889-024-21072-w.


Adiposity and dementia among Chinese adults: longitudinal study in the China Health and Retirement Longitudinal Study (CHARLS).

Zeng M, Chen Y, Lobanov-Rostovsky S, Liu Y, Steptoe A, Brunner E Int J Obes (Lond). 2024; .

PMID: 39695279 DOI: 10.1038/s41366-024-01698-x.